- Home
- TRVI vs IPI Comparison
TRVI vs IPI Comparison
Compare TRVI & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- IPI
- Stock Information
- Founded
- TRVI 2011
- IPI 2000
- Country
- TRVI United States
- IPI United States
- Employees
- TRVI N/A
- IPI N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- TRVI Health Care
- IPI Industrials
- Exchange
- TRVI Nasdaq
- IPI Nasdaq
- Market Cap
- TRVI 341.4M
- IPI 347.7M
- IPO Year
- TRVI 2019
- IPI 2008
- Fundamental
- Price
- TRVI $4.24
- IPI $26.78
- Analyst Decision
- TRVI Strong Buy
- IPI Sell
- Analyst Count
- TRVI 8
- IPI 2
- Target Price
- TRVI $9.31
- IPI $22.00
- AVG Volume (30 Days)
- TRVI 454.6K
- IPI 129.6K
- Earning Date
- TRVI 03-19-2025
- IPI 03-05-2025
- Dividend Yield
- TRVI N/A
- IPI N/A
- EPS Growth
- TRVI N/A
- IPI N/A
- EPS
- TRVI N/A
- IPI N/A
- Revenue
- TRVI N/A
- IPI $206,359,000.00
- Revenue This Year
- TRVI N/A
- IPI N/A
- Revenue Next Year
- TRVI N/A
- IPI $3.40
- P/E Ratio
- TRVI N/A
- IPI N/A
- Revenue Growth
- TRVI N/A
- IPI N/A
- 52 Week Low
- TRVI $1.39
- IPI $17.52
- 52 Week High
- TRVI $4.68
- IPI $29.75
- Technical
- Relative Strength Index (RSI)
- TRVI 60.00
- IPI 56.88
- Support Level
- TRVI $3.81
- IPI $25.97
- Resistance Level
- TRVI $4.04
- IPI $28.90
- Average True Range (ATR)
- TRVI 0.25
- IPI 1.16
- MACD
- TRVI -0.00
- IPI -0.00
- Stochastic Oscillator
- TRVI 90.89
- IPI 27.89
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.